Acute kidney injury and morbi‐mortality associated with “triple whammy” combination: Systematic review and meta‐analysis
British Journal of Clinical Pharmacology · 2025-11 · 91 (11) · 3031-3041
DOI: 10.1002/bcp.70263 ↗Kurz gefasst
Metaanalyse in der Zeitschrift British Journal of Clinical Pharmacology, online erschienen am 28.08.2025. Verfasst von Dulce María Calvo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Autonomous University of Barcelona (UAB), Barcelona, Spain. Hauptthemen laut MEDLINE: Acute Kidney Injury, Angiotensin Receptor Antagonists, Angiotensin-Converting Enzyme Inhibitors, Anti-Inflammatory Agents, Non-Steroidal. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European Regional Development Fund, Government of Navarre (Spain), Departamento de Salud, Gobierno de Navarra.
Abstract (Originalsprache)
Aims “Triple whammy” (TW) refers to the concomitant use of diuretics, renin‐angiotensin‐aldosterone system inhibitors (RAASI) and non‐steroidal anti‐inflammatory drugs (NSAIDs). The aim of this article is to analyse the association between TW exposure and acute kidney injury (AKI), among other morbi‐mortality outcomes.
Methods
We included studies published up to August 2023 in the Cochrane Library, Medline or EMBASE, among others. The risk of AKI within 12 months after TW vs . not exposed to TW was the main outcome.
Results
We included five case–control studies, involving 410 130 participants. The risk of AKI was significantly higher among those exposed to TW vs . not exposed (odds ratio [OR] 2.01, 95% confidence interval [CI] 1.30–3.10; four studies; I 2 : 90%; low certainty of evidence). Three studies provided data on all‐cause mortality, not showing a significantly higher risk with TW exposure (very low certainty of evidence).
Conclusion
The available evidence reveals that TW may lead to a significantly higher risk of AKI and related hospitalizations, with no detrimental effect on mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Autonomous University of Barcelona (UAB), Barcelona, Spain.
- Innovation and Organization Unit, Navarre Health Service, Pamplona, Spain.
- Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.
- Pharmacy and Services Sub-Directorate, Navarre Health Service, Pamplona, Spain.
ORCID-Profile: Dulce María Calvo, Luis Carlos Saiz, Leire Leache, Maria Concepción Celaya, Marta Gutiérrez-Valencia
Förderung
- European Regional Development Fund
- Government of Navarre (Spain)
- Departamento de Salud, Gobierno de Navarra
Zitieren
APA
Calvo, D. M., Saiz, L. C., Leache, L., Celaya, M. C., & Gutiérrez-Valencia, M. (2025). Acute kidney injury and morbi‐mortality associated with “triple whammy” combination: Systematic review and meta‐analysis. British Journal of Clinical Pharmacology, 91(11), 3031-3041. https://doi.org/10.1002/bcp.70263
Vancouver
Calvo DM, Saiz LC, Leache L, Celaya MC, Gutiérrez-Valencia M. Acute kidney injury and morbi‐mortality associated with “triple whammy” combination: Systematic review and meta‐analysis. British Journal of Clinical Pharmacology. 2025;91(11):3031-3041. doi:10.1002/bcp.70263
BibTeX
@article{Calvo2025,
author = {Calvo, Dulce María and Saiz, Luis Carlos and Leache, Leire and Celaya, Maria Concepción and Gutiérrez-Valencia, Marta},
title = {Acute kidney injury and morbi‐mortality associated with “triple whammy” combination: Systematic review and meta‐analysis},
journal = {British Journal of Clinical Pharmacology},
year = {2025},
volume = {91},
number = {11},
pages = {3031--3041},
doi = {10.1002/bcp.70263}
}
EUVIMED